NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Sayeda Kamrun Naher
AD Scientific Index 2024
Medical and Health Sciences / Medical Oncology
University of Sydney - Sydney / Australia
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Sayeda Kamrun Naher's MOST POPULAR ARTICLES
1-)
An updated systematic review of quantitative studies assessing anxiety, depression, fear of cancer recurrence or psychological distress in testicular cancer survivorsO Rincones, AB Smith, S Naher, R Mercieca-Bebber, M StocklerCancer Management and Research, 3803-3816, 2021192021
2-)
Patient-reported outcomes associated with treatments for testicular cancer: a systematic reviewR Mercieca-Bebber, SK Naher, O Rincones, AB Smith, MR StocklerPatient Related Outcome Measures, 129-171, 202192021
3-)
Patterns of care and outcomes among triple‐negative early breast cancer patients in South Western SydneyS Naher, A Tognela, E Moylan, DH Adams, BE KielyInternal Medicine Journal 48 (5), 567-572, 201872018
4-)
ALT-GIST: Randomized phase II trial of imatinib alternating with regorafenib versus imatinib alone for the first-line treatment of metastatic gastrointestinal stromal tumor (GIST).D Yip, JR Zalcberg, JY Blay, M Eriksson, D Espinoza, TJ Price, ...Journal of Clinical Oncology 37 (15_suppl), 11023-11023, 201962019
5-)
Chemotherapy in resectable or potentially resectable colon cancer with liver metastasesZ Samoon, SK Naher, KM Sjoquist, J ZalcbergExpert Opinion on Pharmacotherapy 23 (6), 663-672, 202232022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept